Showing results (1141-1150 of 1,184) with videos related to

Sort By:
Pageof 119
International Journal of Molecular Sciences|March 14, 2026
Tubular Damage Biomarkers Are a Useful Tool for Identifying Early Renal Injury in Long COVIDCaio V B Menário, Rodrigo P Silva-Aguiar, Douglas E Teixeira, et al.
Journal of Molecular Microbiology and Biotechnology|March 10, 2016
Anaerobic Microbial Degradation of Hydrocarbons: From Enzymatic Reactions to the EnvironmentRalf Rabus, Matthias Boll, Johann Heider, et al.
Nature Medicine|November 28, 2018
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancerKhyati N Shah, Roma Bhatt, Julia Rotow, et al.
NPJ Primary Care Respiratory Medicine|October 25, 2024
Living with COPD and its psychological effects on participating in community-based physical activity in Brazil: a qualitative study. Findings from the Breathe Well groupS M Martins, R Adams, E M Rodrigues, et al.
Nature Communications|October 17, 2024
Depth-dependent study of time-reversal symmetry-breaking in the kagome superconductor AV3Sb5J N Graham, C Mielke Iii, D Das, et al.
Rheumatology (Oxford, England)|September 1, 2014
DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.ptFernando M Martins, José António Pereira da Silva, Maria José Santos, et al.
BMJ Open|September 24, 2021
Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (≥40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well groupZihan Pan, Andrew P Dickens, Chunhua Chi, et al.
Archives of Endocrinology and Metabolism|January 10, 2019
A pioneering RET genetic screening study in the State of Ceará, Brazil, evaluating patients with medullary thyroid cancer and at-risk relatives: experience with 247 individualsMaria Cecília Martins-Costa, Susan C Lindsey, Lucas L Cunha, et al.
Annals of the Rheumatic Diseases|March 21, 2020
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritisElsa Vieira-Sousa, Pedro Alves, Ana M Rodrigues, et al.
Plant Biotechnology Journal|June 8, 2025
Modulating the activity of the APC/C regulator SISAMBA improves the sugar and antioxidant content of tomato fruitsPerla Novais de Oliveira, Leonardo Perez de Souza, Pedro Boscariol Ferreira, et al.
Pageof 119